Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P250012/S008

Simplera Sync Sensor

Medtronic MiniMed, Inc. · Decision date Jun 12, 2026

FDA DECISIONP250012/S008

What did the FDA approve?

FDA records P250012/S008 as a supplement to PMA P250012, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jun 12, 2026.

FDA approval order statement

Approval for updating the sensor compressor dimensions in the Synergy Sensor (Simplera) assembly.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Clinical Chemistry
Decision date
Jun 12, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P250012/S008
Regulatory pathway
PMA supplement
Product code
SFI
Decision code
APPR
Decision date
Jun 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Sensor, Glucose, Invasive, Component of automated insulin delivery system.

Product code
SFI
FDA device class
3

For the original device and its historical approval scope, see PMA P250012. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P250012 · Original PMA

    Simplera Sync Sensor, Guardian 4 Sensor

  2. P250012/S001 · Related supplement

    Simplera Sync Sensor, Guardian 4 Sensor

  3. P250012/S003 · Related supplement

    Simplera Sync Sensor, Guardian 4 Sensor

  4. P250012/S004 · Related supplement

    Simplera Sync Sensor, Guardian 4 Sensor

  5. P250012/S005 · Related supplement

    Simplera Sync Sensor; Guardian 4 Sensor

  6. P250012/S008 received

    Application receipt date recorded by FDA.

  7. P250012/S010 · Related supplement

    Simplera and Simplera Sync

  8. P250012/S008 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P250012. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P250012

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic MiniMed, Inc.PMA approvalAug 6, 2025FDA
Medtronic MiniMed, Inc.PMA supplementAug 25, 2025FDA
Medtronic MiniMed, Inc.PMA supplementSep 12, 2025FDA
Guardian 4 SensorP250012/S002
Medtronic MiniMed, Inc.PMA supplementOct 9, 2025FDA
Medtronic MiniMed, Inc.PMA supplementOct 16, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 5, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 8, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 10, 2025FDA
Medtronic MiniMed, Inc.PMA supplementMar 19, 2026FDA
Medtronic MiniMed, Inc.PMA supplementMay 26, 2026FDA
Simplera SyncP250012/S011
Medtronic MiniMed, Inc.PMA supplementJul 21, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic MiniMed, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
18000 Devonshire St., Northridge, CA, 91325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records